Citi Starts BridgeBio Pharma (BBIO) at Buy, 'shares are compelling'
Tweet Send to a Friend
(Updated - November 7, 2023 4:31 AM EST)
Citi analyst David Lebowitz initiates coverage on BridgeBio Pharma (NASDAQ: BBIO) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Citi analyst David Lebowitz initiates coverage on BridgeBio Pharma (NASDAQ: BBIO) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
